GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Anhui Huaren Health Pharmaceutical Co Ltd (SZSE:301408) » Definitions » Total Assets

Anhui Huaren Health Pharmaceutical Co (SZSE:301408) Total Assets : ¥4,938 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Anhui Huaren Health Pharmaceutical Co Total Assets?

Anhui Huaren Health Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥4,938 Mil.

Warning Sign:

If a company builds assets at 32% a year, faster than its revenue growth rate of 21.4% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Anhui Huaren Health Pharmaceutical Co's average Total Assets Growth Rate was 59.50% per year. During the past 3 years, the average Total Assets Growth Rate was 29.50% per year. During the past 5 years, the average Total Assets Growth Rate was 32.00% per year.

During the past 6 years, Anhui Huaren Health Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 33.20%. The lowest was 28.10%. And the median was 29.50%.

Total Assets is connected with ROA %. Anhui Huaren Health Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 was 4.00%. Total Assets is also linked to Revenue through Asset Turnover. Anhui Huaren Health Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.23.


Anhui Huaren Health Pharmaceutical Co Total Assets Historical Data

The historical data trend for Anhui Huaren Health Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Huaren Health Pharmaceutical Co Total Assets Chart

Anhui Huaren Health Pharmaceutical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial 1,066.32 1,712.42 1,971.05 2,576.19 4,611.70

Anhui Huaren Health Pharmaceutical Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,614.60 3,848.78 4,427.48 4,611.70 4,937.86

Anhui Huaren Health Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Anhui Huaren Health Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=1976.53+2635.168
=4,612

Anhui Huaren Health Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=2035.28+2902.583
=4,938

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anhui Huaren Health Pharmaceutical Co  (SZSE:301408) Total Assets Explanation

Total Assets is connected with ROA %.

Anhui Huaren Health Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=191.088/( (4611.698+4937.863)/ 2 )
=191.088/4774.7805
=4.00 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Anhui Huaren Health Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1104.367/( (4611.698+4937.863)/ 2 )
=1104.367/4774.7805
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Anhui Huaren Health Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Anhui Huaren Health Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Anhui Huaren Health Pharmaceutical Co (SZSE:301408) Business Description

Traded in Other Exchanges
N/A
Address
Shanghai Road, Chinese Health Building, No.18, Baohe Industrial Zone, Anhui Province, Hefei, CHN, 230051
Anhui Huaren Health Pharmaceutical Co Ltd focuses on the pharmaceutical retail industry and forms a retail chain, retail centralized procurement, retail service, and retail e-commerce system.
Executives
Yin Jun Directors, executives

Anhui Huaren Health Pharmaceutical Co (SZSE:301408) Headlines

No Headlines